These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 15566514)

  • 1. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
    Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.
    Ishii H; Okada S; Sato T; Nose H; Okusaka T; Yoshimori M; Takayasu K; Takayama T; Kosuge T; Yamasaki S
    Hepatogastroenterology; 1996; 43(9):644-50. PubMed ID: 8799409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
    Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
    Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system].
    Morimoto M; Numata K; Sugimori K; Shirato K; Kokawa A; Oka H; Hirao M; Hirasawa K; Ko R; Saitou T; Imada T; Tanaka K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1592-5. PubMed ID: 16315880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    Hepatogastroenterology; 2007 Jun; 54(76):985-9. PubMed ID: 17629022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
    Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT
    J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
    Horigome H; Nomura T; Saso K; Itoh M
    Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
    Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
    Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.
    Tateishi R; Shiina S; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Yoshida H; Kawabe T; Omata M
    Cancer; 2005 Mar; 103(6):1201-9. PubMed ID: 15690326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful laparoscopic radiofrequency ablation of hepatocellular carcinoma adhered to the mesentery after transcatheter arterial embolization.
    Kurokohchi K; Masaki T; Himoto T; Deguchi A; Nakai S; Yoneyama H; Yoshida S; Kimura Y; Inoue H; Kinekawa F; Yoshitake A; Izuishi K; Watanabe S; Kuriyama S
    Oncol Rep; 2005 Jan; 13(1):65-8. PubMed ID: 15583803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-surgical (medical) treatment of hepatocellular carcinoma (HCC)].
    Tanikawa K
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):34-9. PubMed ID: 2536269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.